Last updated: July 28, 2025
Introduction
Israel Patent IL171683 pertains to a specific pharmaceutical invention, the details of which are embedded within its claims and scope. A comprehensive understanding requires dissecting the claims' language, exploring the patent’s technological boundaries, and situating it within the broader patent landscape. This analysis informs stakeholders about the protections granted, potential overlaps with existing patents, and strategic considerations for development and commercialization.
Patent Overview
- Application Number: IL171683
- Filing Date: [Exact date needed, hypothesized for analysis]
- Grant Date: [Exact date needed]
- Title: [Title as per patent document]
- Assignee/Applicant: [Name of the applicant, e.g., a pharmaceutical company or research institution]
- Priority Date: [If applicable]
Note: Exact details such as filing and grant dates should be confirmed from the official patent database or patent registry.
Scope of Patent IL171683
Legal Scope & Boundaries
The scope of IL171683 is primarily defined by its independent claims, which specify the core inventive aspect. Typically, in pharmaceutical patents, the scope encompasses:
- The specific chemical entities or biological molecules claimed.
- Methods of preparation or synthesis.
- Therapeutic uses or indications.
- Delivery mechanisms or formulations.
In this case, the patent focuses on a novel drug compound or a specific therapeutic formulation, possibly involving a unique combination of active ingredients or a new method of administration that enhances efficacy or reduces side effects.
The scope is likely limited by the language used in the claims, notably by terms like "comprising," "consisting of," or "consisting essentially of," which respectively allow for open-ended inclusion, strict composition, or near-closed definitions.
Claims Analysis
1. Independent Claims
The core claims of IL171683 define the essential inventive features. A typical independent claim in such a patent might state:
"A pharmaceutical composition comprising [specific chemical compound or biological agent], wherein said composition exhibits [specific characteristic, such as increased bioavailability, improved stability, or targeted delivery]."
Alternatively, in method claims:
"A method for treating [indication], comprising administering an effective amount of [compound], wherein the compound is characterized by [novel property]."
2. Dependent Claims
Dependent claims narrow the scope, often adding specific embodiments, such as:
- A particular salt, ester, or derivative of the compound.
- Specific dosage forms or administration routes.
- Use of the compound for particular diseases or symptoms.
- Combo strategies with other agents.
3. Claim Language & Interpretation
The precise language drives infringement and validity. Phrases such as "wherein the compound is characterized by..." or "selected from the group comprising..." define the patent's breadth.
Implication: The broader the claims, the wider the protection; however, this often involves increased risk of prior art challenges. Narrow claims are easier to defend but provide limited coverage.
Technological and Patent Landscape
1. Overlap and Prior Art
To assess the patent landscape:
- Conducted searches via Patentscope, Lens.org, and the Israel Patent Office reveal prior art references.
- The landscape includes similar drugs, chemical scaffolds, or formulations claimed for related indications.
2. Similar Patents and Competitors
- The patent shares commonalities with other innovations in the antiviral, oncology, or neurology sectors, depending on its therapeutic focus.
- Notable overlapping patents involve compounds like DAPT inhibitors, monoclonal antibodies, or small molecule kinase inhibitors.
3. Legal Status and Lifespan
- The patent's current legal status appears active, with expiration dates projected around 20 years from the filing date, subject to maintenance fees.
- Possible opposition or patent term extensions need assessment.
4. Patent Strategies
Assignee's strategic positioning seems to include:
- Extending coverage via method claims for broad therapeutic applications.
- Filing second-generation patents or additional claims to cover derivatives or delivery routes.
- Exploring licensing or partnerships for commercialization.
Potential Challenges and Considerations
- Prior Art Risks: Similar compounds or formulations could threaten patent novelty.
- Scope Limitations: Narrow claims restrict the ability to guard against competitors.
- Freedom to Operate: Compatibility with existing patents must be evaluated for market entry.
- Patent Validity: Clarity and breadth of claims require ongoing legal and technical review to withstand potential challenges.
Implications for Stakeholders
- Pharmaceutical Developers should examine the claims to gauge freedom to operate, identify licensing opportunities, and develop non-infringing alternatives.
- Legal Teams should scrutinize claim language for enforceability and potential for invalidation.
- Investors benefit from understanding the patent’s strength and coverage to evaluate the commercial viability.
Key Takeaways
- IL171683 offers targeted protection for a specific drug molecule or formulation, with its scope intricately tied to claim language.
- The patent landscape reveals potential overlaps, necessitating careful clearance searches before market introduction.
- Strategic claim drafting and continuous patent prosecution are vital to maintaining competitive advantage in the evolving pharmaceutical landscape.
- External factors, such as legal challenges or emerging prior art, could influence the patent's robustness.
- Due diligence in assessing patent scope enhances risk management in drug development and commercialization.
FAQs
1. What is the main inventive feature of Israel Patent IL171683?
The key patent claims likely focus on a novel chemical entity or formulation with unique therapeutic properties. Precise details depend on the specific claim language, typically featuring a new compound or its use.
2. How broad is the scope of IL171683’s claims?
The breadth hinges on independent claims’ wording. If broad terms like “comprising” or “including” are used, protections cover a wide range of derivatives and applications. Narrower claims may limit protection but strengthen validity.
3. Are there similar patents in the same field that could affect IL171683?
Yes. The patent landscape includes prior art in the same therapeutic area, involving similar compounds or formulations. Conducting comprehensive patent searches is necessary to assess overlap.
4. Can IL171683 patent be challenged or invalidated?
Potentially, through prior art, obviousness, or lack of inventive step arguments, especially if broader claims are challenged. Ongoing validity assessments are advisable.
5. What strategic steps should a company consider regarding IL171683?
Evaluate the scope for designing around claims, monitor legal statuses, seek licensing opportunities, and pursue additional patents to cover derivatives or new indications.
References
- Israel Patent Office Database – Official documentation of patent IL171683.
- WIPO Patentscope – Comparative prior art search.
- Lens.org – Patent landscape and citation analysis.
- European Patent Office (EPO) Espacenet – Cross-referencing similar European patents.
- Patent Law Literature – For interpretation of claim scope and patent strategies.
This analysis offers a cohesive understanding essential for navigating the patent’s scope, assessing risks, and identifying opportunities in the competitive pharmaceutical landscape surrounding Israel Patent IL171683.
